BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 21220473)

  • 1. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
    Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
    Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
    Xu Y; Huang Z; Liu Y
    Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
    Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
    Jiang L; Huang Q; Chang J; Wang E; Qiu X
    Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
    Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H
    Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of miR-146a in gastric cancer cases.
    Kogo R; Mimori K; Tanaka F; Komune S; Mori M
    Clin Cancer Res; 2011 Jul; 17(13):4277-84. PubMed ID: 21632853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.
    Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N
    J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells.
    Bao W; Fu HJ; Xie QS; Wang L; Zhang R; Guo ZY; Zhao J; Meng YL; Ren XL; Wang T; Li Q; Jin BQ; Yao LB; Wang RA; Fan DM; Chen SY; Jia LT; Yang AG
    Gastroenterology; 2011 Dec; 141(6):2076-2087.e6. PubMed ID: 21925125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
    Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
    Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells.
    Li D; Yang P; Xiong Q; Song X; Yang X; Liu L; Yuan W; Rui YC
    J Hypertens; 2010 Aug; 28(8):1646-54. PubMed ID: 20531225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.